David Baltimore

David Baltimore

Directeur/Membre du Conseil chez REGULUS THERAPEUTICS INC.

Fortune : 4 568 $ au 30/06/2024

86 ans
Health Technology
Finance
Commercial Services

Profil

David Baltimore is the founder of Helixis, Inc. (founded in 2007), Calimmune, Inc. (founded in 2006), Appia Bio, Inc. (founded in 2020), and Immune Design Corp.
(founded in 1997).
He is currently the Vice Chairman at The Damon Runyon Cancer Research Foundation, Director at FasterCures, Independent Director at Regulus Therapeutics, Inc., Director at The Broad Institute, Inc., Director at The Broad Foundations, Director at Foundation for Biomedical Research, Independent Director at Altos Labs, Inc., Trustee at The Jackson Laboratory, Science Partner at The Column Group LLC, and Member at Human Genome Organisation.
He has held former positions as Vice Chairman at BB Biotech AG (2010), Chairman at MPM BioImpact, Inc., Chairman & President at American Association for the Advancement of Science (2007-2009), Independent Director at Amgen, Inc. (2011-2018), Director at MedImmune LLC (2003-2007), Director & Member at Whitehead Institute for Biomedical Research, Director at Medimmune, Inc. (2003-2007), and Professor at Massachusetts Institute of Technology (1972-1997).
He was also President-Emeritus & Professor-Biology at California Institute of Technology (1997-2006), Professor at The Rockefeller University (1991-1994), and Professor at American Cancer Society California Division, Inc. (1983).
Dr. Baltimore received his undergraduate degree from Swarthmore College and his doctorate degree from The Rockefeller University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
20/05/2024 2 559 ( 0,00% ) 4 568 $ 30/06/2024

Postes actifs de David Baltimore

SociétésPosteDébut
REGULUS THERAPEUTICS INC. Directeur/Membre du Conseil 01/01/2009
Human Genome Organisation Corporate Officer/Principal 15/04/2011
Fondateur 01/01/2020
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
FasterCures Directeur/Membre du Conseil 27/05/2011
Directeur/Membre du Conseil 15/04/2011
Fondateur 01/01/2008
Directeur/Membre du Conseil 13/09/2009
░░░ ░░░░░░ ░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
Tous les postes actifs de David Baltimore

Anciens postes connus de David Baltimore

SociétésPosteFin
░░░░░░ ░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░ ░░░░░░░ ░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░ ░░░ ░░░ ░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░░░░ ░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de David Baltimore

Formation de David Baltimore

The Rockefeller University Doctorate Degree
Swarthmore College Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de David Baltimore

Relations

100 +

Relations au 1er degré

27

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées3
BB BIOTECH AG

Finance

REGULUS THERAPEUTICS INC.

Health Technology

AMGEN INC.

Health Technology

Entreprise privées20

Health Technology

Commercial Services

Commercial Services

Finance

Finance

Health Technology

Health Technology

Health Technology

Commercial Services

Health Services

Human Genome Organisation

FasterCures

Finance

Health Technology

Commercial Services

Medimmune, Inc.

Health Technology

Consumer Non-Durables

Health Services

Health Technology

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. David Baltimore